Company: MLTX
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001213900-25-052140
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-06-06
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07. Submission of Matters to a Vote of Security Holders.

On Thursday, June 5, 2025, MoonLake Immunotherapeutics
(the “ Company”) held its 2025 Annual General Meeting of Shareholders (the “ Annual Meeting”). As of the close of
business on April 10, 2025, the record date for the Annual Meeting, there were 63,474,253 Class A Ordinary Shares and 729,320 Class C
Ordinary Shares entitled to vote at the meeting. At the Annual Meeting, each of the Company’s director nominees was elected and
the other proposals voted on were approved. The final voting results are set forth below:

                                                           Votes                      Votes                        Broker                    
                                                           For                        Withheld                     Non-Votes                 
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Proposal 1. Election of Class III Director Nominees                                                                                        
  ● Dr. Jorge Santos da Silva                                         53,083,965                      499,130                     5,738,408  
  ● Simon Sturge                                                      52,034,156                    1,548,939                     5,738,408  
  ● Dr. Andrew Phillips                                               53,338,613                      244,482                     5,738,408  

                                                                             Votes                      Votes                   Abstentions                 Broker     
                                                                             For                        Against                                             Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Proposal 2. Ratification,                                                             59,310,209                   2,856                       8,438                 

                                                           Votes                      Votes                     Abstentions                 Broker     
                                                           For                        Against                                               Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Proposal 3: Advisory Vote on Executive Compensation                 53,464,199                   109,913                       8,983                 

SIGNATURE